Talwar Drugs Private Limited
About Talwar Drugs Private Limited
Data last updated:
Talwar Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 June 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1995PTC020602. Its GSTIN is 05AAACT7350F1ZK (Uttarakhand). The company holds 7 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Aman Talwar (Whole-Time Director) and Deepak Kumar Talwar.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Flat No.117 Bhanu Enclavenear Esi Erragadda, Hyderabad, Telangana, India – 500038.
As per the financials filed for FY 2019, the company reported a revenue of ₹3.16 Cr, a decline of 33% compared to the previous year. For the same year it recorded a net profit of ₹1.47 Lakh (net margin 0.5%) and EBITDA of ₹12.1 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 102% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Talwar Drugs has one previous CIN (Corporate Identification Number): U24230AP1995PTC020602. The current CIN is U24230TG1995PTC020602, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1995PTC020602 | Current |
| U24230AP1995PTC020602 | Previous |
Contact details
Talwar Drugs Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No.117 Bhanu Enclavenear Esi Erragadda, Hyderabad, Telangana, India – 500038
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Talwar Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Talwar Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Talwar Drugs Private Limited, buy the company report.
Financials of Talwar Drugs Private Limited
FY 2019 filings availableTalwar Drugs Private Limited reported revenue of ₹3.16 Cr (down 33% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue fell 33% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹3.16 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Talwar Drugs Private Limited, buy the company report.
Board of directors of Talwar Drugs Private Limited
Talwar Drugs has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Kumar Talwar | Director | 29 Sep 2001 | 25 Years 1 Months | Current |
| Aman Talwar | Whole-Time Director | 07 Sep 2012 | 14 Years 2 Months | Current |
| Renu Talwar | Director | 31 Jul 2014 | 12 Years 3 Months | Current |
Peer comparison
Talwar Drugs Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Joodsh International Private Limited | ₹3.18 Cr (FY 2021) | -70.0% | Pune, Maharashtra, India | |||
| Patson Laboratories Private Limited | ₹3.17 Cr (FY 2025) | 50.0% | Ahmedabad, Gujarat, India | |||
| Talwar Drugs Private Limitedthis company | ₹3.16 Cr (FY 2019) | ₹1.47 Lakh | 0.5% | -33.0% | Hyderabad, Telangana, India | |
| RX Healthcare Limited | ₹3.16 Cr (FY 2024) | 7.0% | New Delhi, Delhi, India |
To see the full peer comparison of Talwar Drugs Private Limited, buy the company report.
Auditor
Talwar Drugs Private Limited is audited by P MURALI & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P MURALI & CO | FY 2019 | 007257S |
Shareholding
The shareholding of Talwar Drugs Private Limited is on record for 5 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Talwar Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Talwar Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Talwar Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Talwar Drugs has 7 GST registrations: 1 active and 6 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAACT7350F1ZK | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Talwar Drugs Private Limited, buy the company report.
Recent activity
Talwar Drugs Private Limited has 4 board changes on record since 2001: 3 appointments and 1 cessation. The latest: Surender Kumar Talwar ceased to be Director on 12 Aug 2014.
Frequently asked questions
Talwar Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 June 1995 (31+ years old) and is registered under CIN U24230TG1995PTC020602.
Talwar Drugs has 3 current directors:
- Aman Talwar - Whole-Time Director
- Deepak Kumar Talwar - Director
- Renu Talwar - Director
The latest financial statements of Talwar Drugs on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Talwar Drugs is 05AAACT7350F1ZK, registered in Uttarakhand. The company has 7 GST registrations in all, of which 1 is active and 6 are cancelled or inactive.
The CIN (Corporate Identification Number) of Talwar Drugs is U24230TG1995PTC020602. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Talwar Drugs was incorporated on 06 June 1995, making it 31+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Talwar Drugs by revenue are Joodsh International Private Limited, Patson Laboratories Private Limited, RX Healthcare Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Surender Kumar Talwar ceased to be Director on 12 Aug 2014. Renu Talwar was appointed as Director on 31 Jul 2014. Aman Talwar was appointed as Whole-Time Director on 07 Sep 2012. Talwar Drugs has 4 board changes on record in total.
The registered office of Talwar Drugs is at Flat No.117 Bhanu Enclavenear Esi Erragadda, Hyderabad, Telangana, India – 500038.
Talwar Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Talwar Drugs is compliant as of 21 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
